课题基金 / 基金详情

STEM CELL THERAPIES FOR HUNTINGTON?S DISEASE

STEM CELL THERAPIES FOR HUNTINGTON?S DISEASE
亨廷顿病的干细胞疗法
批准号：
8172613
负责人：
Jan A. Nolta
金额：
$7.6万
依托单位：
UNIVERSITY OF CALIFORNIA AT DAVIS
依托单位国家：
美国
项目类别：
财政年份：
2010
资助国家：
美国
项目状态：
已结题
起止时间：
2010-06-01 至 2011-04-30
来源：
https://reporter.nih.gov/project-details/8172613
关键词：
Cell TherapyComputer Retrieval of Information on Scientific Projects DatabaseFundingGoalsGrantHuntington DiseaseInstitutionNeurodegenerative DisordersPatientsResearchResearch PersonnelResourcesSourceUnited States National Institutes of Healthstem cell therapy

项目摘要

项目成果

Jan A. Nolta的其他基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 这些研究的目标是为亨廷顿病患者开发新的基于细胞的疗法。亨廷顿病是一种致命的神经退行性疾病，目前还没有治愈的方法。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The goal of these studies is to develop new cell-based therapies for patients with Huntington's Disease. Huntington's Disease is a fatal neurodegenerative disorder for which there are currently no cures.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Direct cell to cell transfer of microRNA for tissue repair
Direct cell to cell transfer of microRNA for tissue repair
Direct cell to cell transfer of microRNA for tissue repair
Direct cell to cell transfer of microRNA for tissue repair